Roles of melatonin in fetal programming in compromised pregnancies

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 5380-5401

  Chen, Yu Chieh ^a   Sheen, Jiunn Ming ^a   Tiao, Miao Meng ^a   Tain, You Lin ^a   Huang, Li Tung ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Epigenetic; Fetal programming; Melatonin; Pregnancy; Redox

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; REACTIVE OXYGEN METABOLITE;

ADVERSE OUTCOME; ANTIOXIDANT ACTIVITY; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EPIGENETICS; FETUS DEVELOPMENT; FETUS MATURITY; HISTONE MODIFICATION; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALNUTRITION; MATERNAL NUTRITION; MATERNAL STRESS; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PREGNANCY OUTCOME; REVIEW;

EID: 84875061086     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14035380     Document Type: Review

References (149)

1. Reiter, R.J.; Calvo, J.R.; Karbownik, M.; Qi, W.; Tan, D.X. Melatonin and its relation to the immune system and inflammation. Ann. N. Y. Acad. Sci. 2000, 917, 376-386.
2. Radogna, F.; Diederich, M.; Ghibelli, L. Melatonin: A pleiotropic molecule regulating inflammation. Biochem. Pharmacol. 2010, 80, 1844-1852.
3. Hardeland, R.; Cardinali, D.P.; Srinivasan, V.; Spence, D.W.; Brown, G.M.; Pandi-Perumal, S.R. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 2011, 93, 350-384.
4. Mauriz, J.L.; Collado, P.S.; Veneroso, C.; Reiter, R.J.; González-Gallego, J. A review of the molecular aspects of melatonin's anti-inflammatory actions: Recent insights and new perspectives. J. Pineal Res. 2013, 54, 1-14.
5. Chowdhury, I.; Sengupta, A.; Maitra, S.K. Melatonin: Fifty years of scientific journey from the discovery in bovine pineal gland to delineation of functions in human. Indian J. Biochem. Biophys. 2008, 45, 289-304.
6. Reiter, R.J.; Tan, D.X.; Osuna, C.; Gitto, E. Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci. 2000, 7, 444-458.
7. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolin, I.; Herrera, F.; Martin, V.; Reiter, R.J. Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 2004, 36, 1-9.
8. Korkmaz, A.; Reiter, R.J. Epigenetic regulation: A new research area for melatonin? J. Pineal Res. 2008, 44, 41-44.
9. Korkmaz, A.; Rosales-Corral, S.; Reiter, R.J. Gene regulation by melatonin linked to epigenetic phenomena. Gene 2012, 503, 1-11.
10. Mirick, D.K.; Davis, S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 3306-3313.
11. Reiter, R.J.; Tan, D.X.; Burkhardt, S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech. Ageing Dev. 2002, 123, 1007-1019.
12. Cardinali, D.P.; Pagano, E.S.; Scacchi Bernasconi, P.A.; Reynoso, R.; Scacchi, P. Melatonin and mitochondrial dysfunction in the central nervous system. Horm. Behav. 2013, doi:10.1016/j.yhbeh.2012.02.020.
13. Jan, J.E.; Freeman, R.D.; Fast, D.K. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev. Med. Child Neurol. 1999, 41, 491-500.
14. Dodge, N.N.; Wilson, G.A. Melatonin for treatment of sleep disorders in children with developmental disabilities. J. Child Neurol. 2001, 16, 581-584.
15. Okatani, Y.; Wakatsuki, A.; Reiter, R.J.; Miyahara, Y. Hepatic mitochondrial dysfunction in senescence-accelerated mice: Correction by long-term, orally administered physiological levels of melatonin. J. Pineal Res. 2002, 33,127-133.
16. Gitto, E.; Aversa, S.; Reiter, R.J.; Barberi, I.; Pellegrino, S. Update on the use of melatonin in pediatrics. J. Pineal Res. 2011, 50, 21-28.
17. Chen, Y.C.; Tain, Y.L.; Sheen, J.M.; Huang, L.T. Melatonin utility in neonates and children. J. Formos. Med. Assoc. 2012, 111, 57-66.
18. Tamura, H.; Nakamura, Y.; Terron, M.P.; Flores, L.J.; Manchester, L.C.; Tan, D.X.; Sugino, N.; Reiter, R.J. Melatonin and pregnancy in the human. Reprod. Toxicol. 2008, 25, 291-303.
19. Reiter, R.J.; Tan, D.X.; Manchester, L.C.; Paredes, S.D.; Mayo, J.C.; Sainz, R.M. Melatonin and reproduction revisited. Biol. Reprod. 2009, 81, 445-456.
20. Gitto, E.; Pellegrino, S.; Gitto, P.; Barberi, I.; Reiter, R.J. Oxidative stress of the newborn in the pre- and post-natal period and the clinical utility of melatonin. J. Pineal Res. 2009, 46, 128-139.
21. Aversa, S.; Pellegrino, S.; Barberi, I.; Reiter, R.J.; Gitto, E. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J. Matern. Fetal Neonatal. 2012, 25, 207-221.
22. Harderland, R.; Poeggeler, B. Non-vertebrate melatonin. J. Pineal Res. 2003, 34, 233-241.
23. Hardeland, R.; Pandi-Perumal, S.R.; Cardinali, D.P. Melatonin. Int. J. Biochem. Cell Biol. 2006, 38, 313-316.
24. Facciola, G.; Hidestrand, M.; von Bahr, C.; Tybring, G. Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur. J. Clin. Pharmacol. 2001, 56, 881-888.
25. Dubocovich, M.L.; Delagrange, P.; Krause, D.N.; Sugden, D.; Cardinali, D.P.; Olcese, J. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 2010, 62, 343-380.
26. Hardeland, R.; Tan, D.X.; Reiter, R.J. Kynuramines, metabolites of melatonin and other indoles: The resurrection of an almost forgotten class of biogenic amines. J. Pineal Res. 2009, 47, 109-126.
27. Reiter, R.J.; Korkmaz, A.; Paredes, S.D.; Manchester, L.C.; Tan, D.X. Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides. Neuro. Endocrinol. Lett. 2008, 29, 609-613.
28. Tan, D.X.; Manchester, L.C.; Reiter, R.J.; Qi, W.B.; Karbownik, M.; Calvo, J.R. Significance of melatonin in antioxidative defense system: Reactions and products. Biol. Signals Recept. 2000, 9, 137-159.
29. Acuña-Castroviejo, D.; Martín, M.; Macías, M.; Escames, G.; Leon, J.; Khaldy, H.; Reiter, R.J. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res. 2001, 30, 65-74.
30. Korkmaz, A.; Sanchez-Barcelo, E.J.; Tan, D.X.; Reiter, R.J. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res. Treat. 2009, 115, 13-27.
31. Sandyk, R.; Anastasiadis, P.G.; Anninos, P.A.; Tsagas, N. The pineal gland and spontaneous abortions: Implications for therapy with melatonin and magnetic field. Int. J. Neurosci. 1992, 62, 243-250.
32. Matsuzuka, T.; Sakamoto, N.; Ozawa, M.; Ushitani, A.; Hirabayashi, M.; Kanai, Y. Alleviation of maternal hyperthermia-induced early embryonic death by administration of melatonin to mice. J. Pineal Res. 2005, 39, 217-223.
33. Torres-Farfan, C.; Valenzuela, F.J.; Mondaca, M.; Valenzuela, G.J.; Krause, B.; Herrera, E.A.; Riquelme, R.; Llanos, A.J.; Seron-Ferre, M. Evidence of a role for melatonin in fetal sheep physiology: Direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. J. Physiol. 2008, 586, 4017-4027.
34. Seron-Ferre, M.; Torres-Farfan, C.; Forcelledo, M.L.; Valenzuela, G.J. The development of circadian rhythms in the fetus and neonate. Semin. Perinatol. 2001, 25, 363-370.
35. Serón-Ferré, M.; Mendez, N.; Abarzua-Catalan, L.; Vilches, N.; Valenzuela, F.J.; Reynolds, H.E.; Llanos, A.J.; Rojas, A.; Valenzuela, G.J.; Torres-Farfan, C. Circadian rhythms in the fetus. Mol. Cell Endocrinol. 2012, 349, 68-75.
36. Reppert, S.M.; Weaver, D.R.; Rivkees, S.A.; Stopa, E.G. Putative melatonin receptor in a human biological clock. Science 1998, 242, 78-81.
37. Wu, Y.H.; Zhou, J.N.; Balesar, R.; Unmehopa, U.; Bao, A.; Jockers, R.; Van Heerikhuize, J.; Swaab, D.F. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J. Comp. Neurol. 2006, 499, 897-910.
38. Simonneaux, V. Naughty melatonin: How mothers tick off their fetus. Endocrinology 2011, 152, 1734-1738.
39. Karsch, F.J.; Bittman, E.L.; Foster, D.L.; Goodman, R.L.; Legan, S.J.; Robinson, J.E. Neuroendocrine basis of seasonal reproduction. Recent Prog. Horm. Res. 1984, 40, 185-232.
40. Malpaux, B.; Tricoire, H.; Mailliet, F.; Daveau, A.; Migaud, M.; Skinner, D.C.; Pelletier, J.; Chemineau, P. Melatonin and seasonal reproduction: Understanding the neuroendocrine mechanisms using the sheep as a model. Reprod. Suppl. 2002, 59, 167-179.
41. McMillen, I.C.; Houghton, D.C.; Young, I.R. Melatonin and the development of circadian and seasonal rhythmicity. J. Reprod. Fertil. Suppl. 1995, 49, 137-146.
42. Yellon, S.M.; Longo, L.D. Melatonin rhythms in fetal and maternal circulation during pregnancy in sheep. Am. J. Physiol. 1987, 252, E799-E802.
43. Deguchi, T. Ontogenesis of a biological clock for serotonin: acetyl coenzyme A N-acetyltransferase in pineal gland of rat. Proc. Natl. Acad. Sci. USA 1975, 72, 2814-2818.
44. Yellon, S.M.; Longo, L.D. Effect of maternal pinealectomy and reverse photoperiod on the circadian melatonin rhythm in the sheep and fetus during the last trimester of pregnancy. Biol. Reprod. 1988, 39, 1093-1099.
45. Mcmillen, I.C.; Nowak, R. Maternal pinealectomy abolishes the diurnal rhythm in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation. J. Endocrinol. 1989, 120, 459-464.
46. Torres-Farfan, C.; Richter, H.G.; Germain, A.M.; Valenzuela, G.J.; Campino, C.; Rojas-García, P.; Forcelledo, M.L.; Torrealba, F.; Serón-Ferré, M. Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland. J. Physiol. 2004, 554, 841-856.
47. Bellavía, S.L.; Carpentieri, A.R.; Vaqué, A.M.; Macchione, A.F.; Vermouth, N.T. Pup circadian rhythm entrainment-effect of maternal ganglionectomy or pinealectomy. Physiol. Behav. 2006, 89, 342-349
48. Mendez, N.; Abarzua-Catalan, L.; Vilches, N.; Galdames, H.A.; Spichiger, C.; Richter, H.G.; Valenzuela, G.J.; Seron-Ferre, M.; Torres-Farfan, C. Timed maternal melatonin treatment reverses circadian disruption of the fetal adrenal clock imposed by exposure to constant light. PLoS One 2012, 7, e42713.
49. Chan, W.Y.; Ng, T.B. Development of pre-implantation mouse embryos under the influence of pineal indoles. J. Neural Transm. Gen. Sect. 1994, 96, 19-29.
50. McElhinny, A.S.; Davis, F.C.; Warner, C.M. The effect of melatonin on cleavage rate of C57BL/6 and CBA/Ca preimplantation embryos cultured in vitro. J. Pineal Res. 1996, 21, 44-48.
51. Jahnke, G.; Marr, M.; Myers, C.; Wilson, R.; Travlos, G.; Price, C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol. Sci. 1999, 50, 271-279.
52. Sadowsky, D.W.; Yellon, S.; Mitchell, M.D.; Nathanielsz, P.W. Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142 days gestation (term = 147 days gestation). Endocrinology 1991, 128, 1812-1818.
53. Leach, C.M.; Thorburn, G.D. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins 1980, 20, 51-56.
54. Barker, D.J.; Winter, P.D.; Osmond, C.; Margetts, B.; Simmonds, S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2, 577-580.
55. Chen, M.; Zhang, L. Epigenetic mechanisms in developmental programming of adult disease. Drug Discov. Today 2011, 16, 1007-1018.
56. Hanson, M.; Godfrey, K.M.; Lillycrop, K.A.; Burdge, G.C.; Gluckman, P.D. Developmental plasticity and developmental origins of non-communicable disease: Theoretical considerations and epigenetic mechanisms. Prog. Biophys. Mol. Biol. 2011, 106, 272-280.
57. Hochberg, Z.; Feil, R.; Constancia, M.; Fraga, M.; Junien, C.; Carel, J.C.; Boileau, P.; Le Bouc, Y.; Deal, C.L.; Lillycrop, K.; et al. Child health, developmental plasticity, and epigenetic programming. Endocr. Rev. 2011, 32, 159-224.
58. Thompson, L.P.; Al-Hasan, Y. Impact of oxidative stress in fetal programming. J. Pregnancy 2012, 2012, 582748.
59. Xiong, F.; Zhang, L. Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease. Front. Neuroendocrinol. 2012, 12, 62-63.
60. Luo, Z.C.; Fraser, W.D.; Julien, P.; Deal, C.L.; Audibert, F.; Smith, G.N.; Xiong, X.; Walker, M. Tracing the origins of "fetal origins" of adult diseases: Programming by oxidative stress? Med. Hypotheses 2006, 66, 38-44.
61. Luo, Z.C.; Xiao, L.; Nuyt, A.M. Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J. Diabetes 2010, 1, 89-98.
62. Tarry-Adkins, J.L.; Ozanne, S.E. Mechanisms of early life programming: Current knowledge and future directions. Am. J. Clin. Nutr. 2011, 94, 1765S-1771S.
63. Tamura, H.; Takasaki, A.; Taketani, T.; Tanabe, M.; Kizuka, F.; Lee, L.; Tamura, I.; Maekawa, R.; Aasada, H.; Yamagata, Y.; et al. The role of melatonin as an antioxidant in the follicle. J. Ovarian Res. 2012, 5, 5.
64. Miller, S.L.; Wallace, E.M.; Walker, D.W. Antioxidant therapies: A potential role in perinatal medicine. Neuroendocrinology 2012, 96, 13-23.
65. Nelissen, E.C.; van Montfoort, A.P.; Dumoulin, J.C.; Evers, J.L. Epigenetics and the placenta. Hum. Reprod. Update 2011, 17, 397-417.
66. Huang, L.T.; Hsieh, C.S.; Chang, K.A.; Tain, Y.L. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int. J. Mol. Sci. 2012, 13, 14606-14622.
67. Ribatti, D.; Nico, B.; Crivellato, E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis 2009, 12, 101-111.
68. Dokras, A.; Coffin, J.; Field, L.; Frakes, A.; Lee, H.; Madan, A.; Nelson, T.; Ryu, G.Y.; Yoon, J.G.; Madan, A. Epigenetic regulation of maspin expression in the human placenta. Mol. Hum. Reprod. 2006, 12, 611-617.
69. Longtine, M.S.; Nelson, D.M. Placental dysfunction and fetal programming: The importance of placental size, shape, histopathology, and molecular composition. Semin. Reprod. Med. 2011, 29, 187-196.
70. Yuen, R.K.; Chen, B.; Blair, J.D.; Robinson, W.P.; Nelson, D.M. Hypoxia alters the epigenetic profile in cultured human placental trophoblasts. Epigenetics 2013, 8, 192-202.
71. Rugg-Gunn, P.J. Epigenetic features of the mouse trophoblast. Reprod. Biomed. Online 2012, 25, 21-30.
72. Cerda, S.; Weitzman, S.A. Influence of oxygen radical injury onDNA methylation. Mutat. Res. 1997, 386, 141-152.
73. Hitchler, M.J.; Domann, F.E. An epigenetic perspective on the free radical theory of development. Free Radic. Biol. Med. 2007, 43, 1023-1036.
74. Ziech, D.; Franco, R.; Pappa, A.; Panayiotidis, M.I. Reactive Oxygen Species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 2011, 711, 167-173.
75. Brzezinski, A.; Seibel, M.M.; Lynch, H.J.; Deng, M.H.; Wurtman R.J. Melatonin in human preovulatory follicular fluid. J. Clin. Endocrinol. Metab. 1987, 64, 865-867.
76. Okatani, Y.; Wakatsuki, A.; Shinohara, K.; Kaneda, C.; Fukaya, T. Melatonin stimulates glutathione peroxidase activity in human chorion. J. Pineal Res. 2001, 30, 199-205.
77. Zhu, J.L.; Hjollund, N.H.; Andersen, A.M.; Olsen, J. Shift work, job stress, and late fetal loss: The National Birth Cohort in Denmark. J. Occup. Environ. Med. 2004, 46, 1144-1149.
78. Croteau, A.; Marcoux, S.; Brisson, C. Work activity in pregnancy, preventive measures, and the risk of delivering a small-for-gestational-age infant. Am. J. Public Health 2006, 96, 846-855.
79. Ferreira, D.S.; Amaral, F.G.; Mesquita, C.C.; Barbosa, A.P.; Lellis-Santos, C.; Turati, A.O.; Santos, L.R.; Sollon, C.S.; Gomes, P.R.; Faria, J.A.; et al. Maternal melatonin programs the daily pattern of energy metabolism in adult offspring. PLoS One 2012, 7, e38795.
80. McCurdy, C.E.; Bishop, J.M.; Williams, S.M.; Grayson, B.E.; Smith, M.S.; Friedman, J.E.; Grove, K.L. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J. Clin. Invest. 2009, 119, 323-335.
81. Suter, M.; Bocock, P.; Showalter, L.; Hu, M.; Shope, C.; McKnight, R.; Grove, K.; Lane, R.; Aagaard-Tillery, K. Epigenomics: Maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 2011, 25, 714-726.
82. Sun, Z.; Chin, Y.E.; Zhang, D.D. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell. Biol. 2009, 29, 2658-2672.
83. Kawai, Y.; Garduno, L.; Theodore, M.; Yang, J.; Arinze, I.J. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem. 2011, 286, 7629-7640.
84. Kennaway, D.J. Programming of the fetal suprachiasmatic nucleus and subsequent adult rhythmicity. Trends Endocrinol. Metab. 2002, 13, 398-402.
85. Cagampang, F.R.; Poore, K.R.; Hanson, M.A. Developmental origins of the metabolic syndrome: Body clocks and stress responses. Brain Behav. Immun. 2011, 25, 214-220.
86. Kennaway, D.J.; Goble, F.C.; Stamp, G.E. Factors influencing the development of melatonin rhythmicity in humans. J. Clin. Endocrinol. Metab. 1996, 81, 1525-1532.
87. Holditch-Davis, D.; Edwards, L.J. Temporal organization of sleep-wake states in preterm infants. Dev. Psychobiol. 1998, 33, 257-269.
88. Mirmiran, M.; Maas, Y.G.; Ariagno, R.L. Development of fetal and neonatal sleep and circadian rhythms. Sleep Med. Rev. 2003, 7, 321-334.
89. Muñoz-Hoyos, A.; Rodriguez-Cabezas, T.; Molina-Carballo, A.; Martinez-Sempere, J.J.; Ruiz-Cosano, C.; Acuña-Castroviejo, D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. J. Pineal Res. 1992, 13, 184-191.
90. Simmons, D. Epidemiology of Diabetes in Pregnancy. In Practical Management of Diabetes in Pregnancy; McCance, D., Maresh, M., Eds.; Blackwell Publishing: London, UK, 2010.
91. Muñoz-Hoyos, A.; Bonillo-Perales, A.; Avila-Villegas, R.; González-Ripoll, M.; Uberos, J.; Florido-Navío, J.; Molina-Carballo, A. Melatonin levels during the first week of life and their relation with the antioxidant response in the perinatal period. Neonatology 2007, 92, 209-216.
92. Saito, S.; Tachibana, T.; Choi, Y.H.; Denbow, D.M.; Furuse, M. ICV melatonin reduces acute stress responses in neonatal chicks. Behav. Brain Res. 2005, 165, 197-203.
93. Owens, J.A.; Witmans, M. Sleep problems. Curr. Probl. Pediatr. Adolesc. Health Care 2004, 34, 154-179.
94. Chung, S.S.; Ho, E.C.; Lam, K.S.; Chung, S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 2003, 14, S233-S236.
95. Giugliano, D.; Ceriello, A.; Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996, 19, 257-267.
96. Gao, L.; Mann, G.E. Vascular NAD(P)H oxidase activation in diabetes: A double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82, 9-20.
97. Brownlee, M. The pathological implications of protein glycation. Clin. Invest. Med. 1995, 18, 275-281.
98. Agil, A.; Navarro-Alarcón, M.; Ruiz, R.; Abuhamadah, S.; El-Mir, M.Y.; Vázquez, G.F. Beneficial effects of melatonin on obesity and lipid profile in young zucker diabetic fatty rats. J. Pineal Res. 2011, 50, 207-212.
99. Tan, D.X.; Manchester, L.C.; Fuentes-Broto, L.; Paredes, S.D.; Reiter, R.J. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: Relation to human obesity. Obes. Rev. 2011, 12, 167-188.
100. Liao, S.; Liu, Y.; Tan, Y.; Gan, L.; Mei, J.; Song, W.; Chi, S.; Dong, X.; Chen, X.; Deng, S. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women. PLoS One 2012, 7, e40113.
101. Nistala, R.; Hayden, M.R.; Demarco, V.G.; Henriksen, E.J.; Lackland, D.T.; Sowers, J.R. Prenatal programming and epigenetics in the genesis of the cardiorenal syndrome. Cardiorenal. Med. 2011, 1, 243-254.
102. Garcia-Vargas, L.; Addison, S.S.; Nistala, R.; Kurukulasuriya, D.; Sowers, J.R. Gestational diabetes and the offspring: implications in the development of the cardiorenal metabolic syndrome in offspring. Cardiorenal. Med. 2012, 2, 134-142.
103. Miehle, K.; Stephan, H.; Fasshauer, M. Leptin, adiponectin, and other adipokines in gestational diabetes mellitus and preeclampsia. Clin. Endocrinol. 2012, 76, 2-11.
104. Mandruzzato, G.; Antsaklis, A.; Botet, F.; Chervenak, F.A.; Figueras, F.; Grunebaum, A.; Puerto, B.; Skupski, D.; Stanojevic, M. Intrauterine restriction (IUGR). J. Perinat. Med. 2008, 36, 277-281.
105. Forsén, T.; Eriksson, J.; Tuomilehto, J.; Reunanen, A.; Osmond, C.; Barker, D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann. Intern. Med. 2000, 133, 176-182.
106. Pilgaard, K.; Hammershaimb Mosbech, T.; Grunnet, L.; Eiberg, H.; Van Hall, G.; Fallentin, E.; Larsen, T.; Larsen, R.; Poulsen, P.; Vaag, A. Differential nongenetic impact of birth weight versus third-trimester growth velocity on glucose metabolism and magnetic resonance imaging abdominal obesity in young healthy twins. J. Clin. Endocrinol. Metab. 2011, 96, 2835-2843.
107. Painter, R.C.; de Rooij, S.R.; Bossuyt, P.M.; Simmers, T.A.; Osmond, C.; Barker, D.J.; Bleker, O.P.; Roseboom, T.J. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am. J. Clin. Nutr. 2006, 84, 322-327.
108. Karowicz-Bilinska, A.; Kedziora-Kornatowska, K.; Bartosz, G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic. Res. 2007, 41, 870-873.
109. Biri, A.; Bozkurt, N.; Turp, A.; Kavutcu, M.; Himmetoglu, O.; Durak, I. Role of oxidative stress in intrauterine growth restriction. Gynecol. Obstet. Invest. 2007, 64, 187-192.
110. Mohn, A.; Chiavaroli, V.; Cerruto, M.; Blasetti, A.; Giannini, C.; Bucciarelli, T.; Chiarelli, F. Increased oxidative stress in prepubertal children born small for gestational age. J. Clin. Endocrinol. Metab. 2007, 92, 1372-1378.
111. Cambonie, G.; Comte, B.; Yzydorczyk, C.; Ntimbane, T.; Germain, N.; Le, N.L.; Pladys, P.; Gauthier, C.; Lahaie, I.; Abran, D.; et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R1236-R1245.
112. Maggioni, C.; Cornelissen, G.; Antinozzi, R.; Ferrario, M.; Grafe, A.; Halberg, F. A half-yearly aspect of circulating melatonin in pregnancies complicated by intrauterine growth retardation. Neuro. Endocrinol. Lett. 1999, 20, 55-68.
113. Lemley, C.O.; Meyer, A.M.; Camacho, L.E.; Neville, T.L.; Newman, D.J.; Caton, J.S.; Vonnahme, K.A. Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302, R454-467.
114. Gheorghe, C.P.; Goyal, R.; Mittal, A.; Longo, L.D. Gene expression in the placenta: Maternal stress and epigenetic responses. Int. J. Dev. Biol. 2010, 54, 507-523.
115. Fu, Q.; McKnight, R.A.; Yu, X.; Callaway, C.W.; Lane, R.H. Growth retardation alters the epigenetic characteristics of hepatic dual specificity phosphatase 5. FASEB J. 2006, 20, 2127-2129.
116. Lillycrop, K.A.; Slater-Jefferies, J.L.; Hanson, M.A.; Godfrey, K.M.; Jackson, A.A.; Burdge, G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr. 2007, 97, 1064-1073.
117. Patterson, A.J.; Xiao, D.; Xiong, F.; Dixon, B.; Zhang, L. Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts. Cardiovasc. Res. 2012, 93, 302-310.
118. Pinney, S.E.; Simmons, R.A. Metabolic programming, epigenetics, and gestational diabetes mellitus. Curr. Diab. Rep. 2012, 12, 67-74.
119. Bogdarina, I.; Haase, A.; Langley-Evans, S.; Clark, A.J.L. Glucocorticoid effects on the programming of AT1b angiotensin receptor gene methylation and expression in the rat. PLoS One 2010, 5, e9237.
120. Rexhaj, E.; Bloch, J.; Jayet, P.Y.; Rimoldi, S.F.; Dessen, P.; Mathieu, C.; Tolsa, J.F.; Nicod, P.; Scherrer, U.; Sartori, C. Fetal programming of pulmonary vascular dysfunction in mice: Role of epigenetic mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2011, 301, H247-H252.
121. Ke, X.; Lei, Q.; James, S.J.; Kelleher, S.L.; Melnyk, S.; Jernigan, S.; Yu, X.; Wang, L.; Callaway, C.W.; Gill, G.; et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol. Genom. 2006, 25, 16-28.
122. Raychaudhuri, N.; Raychaudhuri, S.; Thamotharan, M.; Devaskar, S.U. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J. Biol. Chem. 2008, 283, 13611-13626.
123. Noris, M.; Perico, N.; Remuzzi, G. Mechanisms of disease: Pre-eclampsia. Nat. Clin. Pract. Nephrol. 2005, 1, 98-114.
124. Simmons, R.A. Developmental origins of adult disease. Pediatr. Clin. North. Am. 2009, 56, 449-466.
125. Seabra, M.L.; Bignotto, M.; Pinto, L.R., Jr.; Tufik, S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J. Pineal Res. 2000, 29, 193-200.
126. Gitto, E.; Reiter, R.J.; Amodio, A.; Romeo, C.; Cuzzocrea, E.; Sabatino, G.; Buonocore, G.; Cordaro, V.; Trimarchi, G.; Barberi, I. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J. Pineal Res. 2004, 36, 250-255.
127. Lanoix, D.; Guérin, P.; Vaillancourt, C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: New insights into the role of this hormone in pregnancy. J. Pineal Res. 2012, 53, 417-425.
128. Gordon, N. The therapeutics of melatonin: A paediatric perspective. Brain Dev. 2000, 22, 213-217.
129. Kulkarni, A.; Chavan-Gautam, P.; Mehendale, S.; Yadav, H.; Joshi, S. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol. 2011, 30, 79-84.
130. Chim, S.S.; Tong, Y.K.; Chiu, R.W.; Lau, T.K.; Leung, T.N.; Chan, L.Y.; Oudejans, C.B.; Ding, C.; Lo, Y.M. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. USA 2005, 102, 14753-14758.
131. Fowden, A.L.; Giussani, D.A.; Forhead, A.J. Intrauterine programming of physiological systems: Causes and consequences. Physiology (Bethesda) 2006, 21, 29-37.
132. Gupta, P.; Narang, M.; Banerjee, B.D.; Basu, S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: A case control study. BMC Pediatr. 2004, 4, 14.
133. Richter, H.G.; Hansell, J.A.; Raut, S.; Giussani, D.A. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J. Pineal Res. 2009, 46, 357-364.
134. Nagai, R.; Watanabe, K.; Wakatsuki, A.; Hamada, F.; Shinohara, K.; Hayashi, Y.; Imamura, R.; Fukaya, T. Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. J. Pineal Res. 2008, 45, 271-276.
135. Duran, P.; Cintra, L.; Galler, J.R.; Tonkiss, J. Prenatal protein malnutrition induces a phase shift advance of the spontaneous locomotor rhythm and alters the rest/activity ratio in adult rats. Nutr. Neurosci. 2005, 8, 167-172.
136. Stevens, A.; Begum, G.; Cook, A.; Connor, K.; Rumball, C.; Oliver, M.; Challis, J.; Bloomfield, F.; White, A. Epigenetic changes in the hypothalamic proopiomelanocortin and glucocorticoid receptor genes in the ovine fetus after periconceptional undernutrition. Endocrinology 2010, 151, 3652-3664.
137. Lillycrop, K.A.; Phillips, E.S.; Jackson, A.A.; Hanson, M.A.; Burdge, G.C. Dietary protein restriction in the pregnant rat induces altered epigenetic regulation of the glucocorticoid receptor and peroxisomal proliferator-activated receptor alpha in the heart of the offspring which is prevented by folic acid. Proc. Nutr. Soc. 2006, 65, 65A.
138. Burdge, G.C.; Hanson, M.A.; Slater-Jefferies, J.L.; Lillycrop, K.A. Epigenetic regulation of transcription: A mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br. J. Nutr. 2007, 97, 1036-1046.
139. Li, Y.; Gonzalez, P.; Zhang, L. Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: Mechanisms and possible interventions. Prog. Neurobiol. 2012, 98, 145-165.
140. Lui, C.C.; Wang, J.Y.; Tain, Y.L.; Chen, Y.C.; Chang, K.A.; Lai, M.C.; Huang, L.T. Prenatal stress in rat causes long-term spatial memory deficit and hippocampus MRI abnormality: Differential effects of postweaning enriched environment. Neurochem. Int. 2011, 58, 434-441.
141. Weinstock, M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 2001, 65, 427-451.
142. Dugovic, C.; Maccari, S.; Weibel, L.; Turek, F.W.; Van Reeth, O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J. Neurosci. 1999, 19, 8656-8664.
143. Mairesse, J.; Silletti, V.; Laloux, C.; Zuena, A.R.; Giovine, A.; Consolazione, M.; van Camp, G.; Malagodi, M.; Gaetani, S.; Cianci, S.; et al. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. Int. J. Neuropsychopharmacol. 2012, 6, 1-16.
144. Basta, M.; Chrousos, G.P.; Vela-Bueno, A.; Vgontzas, A.N. Chronic insomnia and stress system. Sleep Med. Clin. 2007, 2, 279-291.
145. Allan, S.M.; Rothwell, N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2, 734-744.
146. Soumyarani, V.S.; Jayakumari, N. Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-α, MMP-9, and MMP-2. Mol. Cell Biochem. 2012, 366, 277-285.
147. Darnaudéry, M.; Maccari, S. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res. Rev. 2008, 57, 571-585.
148. Morley-Fletcher, S.; Mairesse, J.; Soumier, A.; Banasr, M.; Fagioli, F.; Gabriel, C.; Mocaer, E.; Daszuta, A.; McEwen, B.; Nicoletti, F.; et al. Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology (Berl) 2011, 217, 301-313.
149. Matrisciano, F.; Tueting, P.; Maccari, S.; Nicoletti, F.; Guidotti, A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology 2012, 37, 929-938.